Apollo Cancer Institute, Chennai

CancerFax acts as your personal coordinator throughout the entire process. You begin by uploading your medical records, including pathology, imaging, and prior treatment history, through our secure platform or via [email protected]. Our clinical team reviews your case and assesses whether Apollo's specialist programmes (surgical oncology, bone marrow transplant, immunotherapy, radiation oncology or clinical trial enrolment) are appropriate for your diagnosis. We then submit your case directly to Apollo Hospitals' international patient services team and work with them to arrange the right department, the right specialist and the right appointment.

Once your consultation is confirmed, CancerFax prepares a full pre-travel briefing covering expected costs, visa documentation requirements, transport to the Teynampet campus, and what to bring on the day. We remain your single point of contact from first enquiry through to consultation completion and post-treatment follow-up. CancerFax charges patients nothing for this service, and we do not add any mark-up to hospital fees. Our goal is to remove every administrative and logistical barrier between you and the treatment you need.

Apollo Cancer Institute Chennai's deepest expertise lies in complex surgical oncology and bone marrow transplantation. The surgical team manages high volumes of hepatobiliary, pancreatic, gastric, esophageal, head and neck, gynaecological, urological, thoracic and breast cancer surgeries, including Whipple, esophagectomy, radical cystectomy with neobladder, cytoreductive surgery with HIPEC, and microvascular reconstruction. The BMT programme is one of South India's most experienced, covering autologous, allogeneic (matched related, matched unrelated and haploidentical) and cord blood transplants for leukaemias, lymphomas, multiple myeloma and selected paediatric indications. Solid tumour medical oncology, immunotherapy, targeted therapy and radiation oncology are available across the full range of cancers. If you are unsure whether your diagnosis falls within Apollo's scope, submit your records through CancerFax and we will confirm eligibility before you make any travel plans.

Apollo Hospitals has initiated CAR-T cell therapy programmes in India and current availability at the Teynampet Cancer Institute should be confirmed at the time of enquiry, as this is an evolving treatment modality in India. CancerFax can verify current CAR-T product availability and patient eligibility before you travel. Proton therapy is not available at the Anna Salai (Teynampet) facility. However, the Apollo Proton Cancer Centre is a separate, dedicated proton beam facility in Vandalur, Chennai, operated by Apollo Hospitals. If proton therapy is clinically indicated for your case (for example, paediatric brain tumours, base of skull tumours or specific re-irradiation scenarios), CancerFax can coordinate a referral and second opinion at the proton centre as part of your Apollo pathway.

Yes. Apollo Hospitals offers remote second opinion services for international patients before they commit to travel. The process typically involves submitting pathology reports, imaging studies and treatment history (ideally in English) to the international patient services team. CancerFax facilitates this submission and follows up with the Apollo clinical team on your behalf to obtain a written opinion or preliminary treatment recommendation, usually within one to two weeks depending on case complexity. This remote review is particularly useful for patients considering BMT, complex surgery, CAR-T eligibility or clinical trial participation before arranging international travel.

Cancer treatment in India typically costs 60 to 80 percent less than equivalent treatment in the United States or Western Europe, while maintaining international quality standards through accreditations such as JCI, NABH and NABL (site-specific status should be confirmed). Indicative ranges from the Apollo international patient services team are autologous BMT in the region of INR 15 to 25 lakhs (approximately USD 18,000 to 30,000) and allogeneic BMT in the region of INR 25 to 45 lakhs (approximately USD 30,000 to 55,000), with major cancer surgery typically INR 3 to 8 lakhs. These are indicative figures only and exact costs depend on cancer type, stage, treatment protocol, duration of stay and supportive care needs. CancerFax requests an itemised cost estimate from Apollo's international desk as part of the pre-travel package and shares it with you at no extra charge. We do not add any mark-up to hospital fees. If you have international health insurance, we can also advise on documentation for reimbursement claims.